Novartis Ag NVS
NYSE NVS
$156.29 +2.35 (+1.53%)
At close: Oct 22, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Non-Current Debt (2010 - 2017)

Updated

Novartis Ag's Non-Current Debt was -$2.11 billion in Q2 2019, compared with -$464 million a year earlier.

Analysis

Novartis Ag (NVS) Non-Current Debt (2010 - 2017) Analysis & Trends

At the end of FY2012, Non-Current Debt at Novartis Ag came in at $13.78 billion, down 0.5% from FY2011.

  • In earlier years, Non-Current Debt was $13.86 billion in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 62.48 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 23.83 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 60.50 Bn
10 Vertex Pharmaceuticals 135.58 Bn 107.59 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -23.16 Bn
Jun 30, 2017 -23.00 Bn
Mar 31, 2017 -22.93 Bn
Sep 30, 2016 -18.26 Bn
Jun 30, 2016 -16.28 Bn
Mar 31, 2016 -16.47 Bn
Dec 31, 2015 -16.33 Bn
Sep 30, 2015 -13.41 Bn
Jun 30, 2015 -13.30 Bn
Mar 31, 2015 -14.83 Bn
Dec 31, 2014 -13.80 Bn
Sep 30, 2014 -12.67 Bn
Mar 31, 2014 -15.20 Bn
Mar 31, 2013 -11.61 Bn
Dec 31, 2012 -13.78 Bn
Sep 30, 2012 -15.82 Bn
Jun 30, 2012 -13.75 Bn
Mar 31, 2012 -13.90 Bn
Dec 31, 2011 -13.86 Bn
Sep 30, 2011 -13.74 Bn
API Access

Novartis Ag Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NVS&period=max&api_key=YOUR_API_KEY